HORIBA opens a 15,000 sq ft methods lab in New Jersey aimed at biopharma customers

The design choice I would look at first is the furniture. Instruments in the plaza are placed on, or bolted to, wheeled tables so they can move between labs as a project needs them ^[12]. Jeff Julien, HORIBA's life science applications manager, said that lets the team reconfigure a room around a customer's problem and bring in technologies "we think could be applicable to those use cases" ^[16].

His example was biopharma. Companies developing therapeutic proteins often depend on several instruments and techniques during development, and Julien said the plaza's scientists can provide those capabilities ^[15]. He described the plaza as HORIBA's answer to "how to leverage what HORIBA does well," moving the customer conversation from "what instrument is needed" to "what problem to solve" ^[1]. According to GEN's account of the opening, HORIBA is presenting its core technologies to that market as an underutilized set of orthogonal tools for applications including biotherapeutic characterization ^[17]. Julien said it changes the way the team thinks about and approaches all of these problems ^[2].

For scale, the plaza is about 15,000 square feet ^[4] inside a facility of about 130,000 ^[10], or roughly 11.5% of the building ^[20]. The rest of the tour covered a working instrument operation: stockrooms, manufacturing, testing and quality-control rooms, and space for training field service engineers ^[13]. The plaza itself holds several labs where HORIBA scientists work on customer projects, plus technical rooms for training application scientists ^[11].

On where the applications support is going, the evidence points most firmly at biopharma. Koutara Kato, executive vice president and assistant general manager for commercial operations at HORIBA Instruments, named semiconductors among the company's markets and listed energy and environment, along with biopharma and healthcare, as areas where it plans to put additional resources ^[7]. Each area "gives us a lot of opportunities and challenges," he said ^[6]. The site takes work in materials, semiconductors and energy as well ^[4]. GEN reports that the New Jersey focus is specifically life science and biopharma ^[19].

Michael Oweimrin, a national sales manager, said the plazas could especially help customers on tight budgets facing rising costs for lab equipment and space ^[8]. "We have a plethora of capabilities to address many different markets," he said ^[9].

The account does not say how many application scientists staff the New Jersey labs, what a customer project costs, or who owns a method developed there. Those answers decide how much an outside team can lean on the site. I think the modular labs and the protein focus make it a useful resource for biotherapeutic characterization, with one condition a buyer should keep in view. A method built on HORIBA instruments will be simplest to reproduce in a lab that owns the same instruments.